(Q42991357)

12 November 2017

Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up (English)

1 reference

12 November 2017

1 reference

1 reference

1

1 reference

12 November 2017

6

Gerken G

1 reference

12 November 2017

Kremp S

2

1 reference

12 November 2017

Höhler T

series ordinal

3

1 reference

12 November 2017

Krummenauer F

series ordinal

4

1 reference

12 November 2017

Schirmacher P

series ordinal

5

1 reference

12 November 2017

1 November 1998

1 reference

Journal of Viral Hepatitis

12 November 2017

1 reference

12 November 2017

5

1 reference

12 November 2017

399-406

1 reference

12 November 2017

6

1 reference

Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA.

12 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Quantification and genotyping of serum HCV-RNA in patients with chronic hepatitis C undergoing interferon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Rapid HLA-DRB1 genotyping by nested PCR amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

MHC class II genes influence the susceptibility to chronic active hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Long-term follow-up of patients with chronic hepatitis C after interferon-alpha treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Differential sensitivity of hepatitis C virus quasispecies to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Host genetic factors influencing the outcome of hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.00127.X

10.1046/J.1365-2893.1998.00127.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference